MGC Pharma receives cannabis cultivation research permit from Australian ODC
SYDNEY: MGC Pharmaceuticals (MXC), a European bio-pharma company specialising in the production and development of phytocannabinoid derived medicines, announced it has been granted a Cannabis Research Cultivation Permit from the Australian Office of Drug Control (ODC). This follows the receipt…